AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.250
-0.150 (-6.25%)
At close: Jun 5, 2026, 4:00 PM EDT
2.320
+0.070 (3.11%)
After-hours: Jun 5, 2026, 7:49 PM EDT

AC Immune Revenue

AC Immune had revenue of 1.12M CHF in the quarter ending March 31, 2026, with 13.03% growth. This brings the company's revenue in the last twelve months to 3.70M, down -86.92% year-over-year. In the year 2025, AC Immune had annual revenue of 3.57M, down -86.92%.

Revenue (ttm)
3.70M CHF
Revenue Growth
-86.92%
P/S Ratio
48.36
Revenue / Employee
30,344 CHF
Employees
122
Market Cap
223.20M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.57M-23.74M-86.92%
Dec 31, 202427.31M12.51M84.51%
Dec 31, 202314.80M10.87M276.14%
Dec 31, 20223.94M--
Dec 31, 2021---
Dec 31, 202015.43M-95.03M-86.03%
Dec 31, 2019110.46M103.54M1,498.03%
Dec 31, 20186.91M-13.34M-65.88%
Dec 31, 201720.26M-2.96M-12.75%
Dec 31, 201623.21M-15.88M-40.61%
Dec 31, 201539.09M8.82M29.14%
Dec 31, 201430.27M21.63M250.46%
Dec 31, 20138.64M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition